Dupont Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,575
| Closed | -$535K | – | 478 |
|
|
2023
Q2 | $535K | Buy |
+14,575
| New | +$567K | 0.03% | 269 |
|
|
2023
Q1 | – | Sell |
-13,946
| Closed | -$715K | – | 1093 |
|
|
2022
Q4 | $715K | Sell |
13,946
-1,344
| -9% | -$64.4K | 0.03% | 459 |
|
|
2022
Q3 | $669K | Sell |
15,290
-44,377
| -74% | -$2.16M | 0.04% | 538 |
|
|
2022
Q2 | $3.13M | Sell |
59,667
-14,294
| -19% | -$728K | 0.15% | 125 |
|
|
2022
Q1 | $3.83M | Sell |
73,961
-27,977
| -27% | -$1.45M | 0.15% | 111 |
|
|
2021
Q4 | $6.02M | Buy |
101,938
+12,968
| +15% | +$643K | 0.21% | 82 |
|
|
2021
Q3 | $3.83M | Sell |
88,970
-40,715
| -31% | -$1.8M | 0.12% | 162 |
|
|
2021
Q2 | $5.08M | Buy |
129,685
+36,798
| +40% | +$1.43M | 0.12% | 130 |
|
|
2021
Q1 | $3.37M | Sell |
92,887
-28,478
| -23% | -$1.01M | 0.08% | 206 |
|
|
2020
Q4 | $4.47M | Sell |
121,365
-17,684
| -13% | -$649K | 0.1% | 159 |
|
|
2020
Q3 | $4.84M | Sell |
139,049
-23,918
| -15% | -$839K | 0.11% | 150 |
|
|
2020
Q2 | $5.06M | Sell |
162,967
-2,976
| -2% | -$101K | 0.11% | 145 |
|
|
2020
Q1 | $5.14M | Buy |
165,943
+37,212
| +29% | +$1.27M | 0.12% | 134 |
|
|
2019
Q4 | $4.79M | Buy |
128,731
+47,011
| +58% | +$1.67M | 0.11% | 158 |
|
|
2019
Q3 | $2.79M | Buy |
81,720
+5,059
| +7% | +$184K | 0.06% | 267 |
|
|
2019
Q2 | $3.15M | Hold |
76,661
| – | – | 0.07% | 258 |
|
|
2019
Q1 | $3.09M | Sell |
76,661
-67,013
| -47% | -$2.68M | 0.07% | 261 |
|
|
2018
Q4 | $5.95M | Sell |
143,674
-31,012
| -18% | -$1.29M | 0.15% | 126 |
|
|
2018
Q3 | $7.3M | Sell |
174,686
-5,797
| -3% | -$223K | 0.16% | 119 |
|
|
2018
Q2 | $6.21M | Sell |
180,483
-75,238
| -29% | -$2.57M | 0.15% | 128 |
|
|
2018
Q1 | $8.61M | Sell |
255,721
-135,074
| -35% | -$4.64M | 0.21% | 91 |
|
|
2017
Q4 | $13.4M | Sell |
390,795
-35,223
| -8% | -$1.2M | 0.31% | 58 |
|
|
2017
Q3 | $14.4M | Sell |
426,018
-38,215
| -8% | -$1.23M | 0.33% | 53 |
|
|
2017
Q2 | $14.8M | Buy |
464,233
+38,581
| +9% | +$1.22M | 0.33% | 56 |
|
|
2017
Q1 | $13.8M | Sell |
425,652
-268,856
| -39% | -$8.48M | 0.31% | 57 |
|
|
2016
Q4 | $21.4M | Sell |
694,508
-469,926
| -40% | -$14.3M | 0.48% | 31 |
|
|
2016
Q3 | $37.4M | Buy |
1,164,434
+124,648
| +12% | +$4.17M | 0.84% | 12 |
|
|
2016
Q2 | $34.7M | Sell |
1,039,786
-93,437
| -8% | -$2.98M | 0.77% | 13 |
|
|
2016
Q1 | $31.9M | Sell |
1,133,223
-68,828
| -6% | -$1.97M | 0.73% | 16 |
|
|
2015
Q4 | $36.8M | Sell |
1,202,051
-363,462
| -23% | -$11.4M | 0.89% | 11 |
|
|
2015
Q3 | $46.7M | Sell |
1,565,513
-502,681
| -24% | -$16.1M | 1.18% | 8 |
|
|
2015
Q2 | $65.8M | Sell |
2,068,194
-82,752
| -4% | -$2.7M | 1.42% | 5 |
|
|
2015
Q1 | $71M | Sell |
2,150,946
-344,486
| -14% | -$11M | 1.39% | 5 |
|
|
2014
Q4 | $73.8M | Buy |
2,495,432
+491,493
| +25% | +$14.1M | 1.36% | 5 |
|
|
2014
Q3 | $56.2M | Buy |
2,003,939
+215,343
| +12% | +$6.04M | 0.97% | 11 |
|
|
2014
Q2 | $50.4M | Sell |
1,788,596
-1,282,430
| -42% | -$36.6M | 0.82% | 16 |
|
|
2014
Q1 | $93.6M | Sell |
3,071,026
-284,617
| -8% | -$8.49M | 1.51% | 9 |
|
|
2013
Q4 | $97.5M | Buy |
3,355,643
+109,120
| +3% | +$3.18M | 1.7% | 7 |
|
|
2013
Q3 | $88.4M | Buy |
3,246,523
+423,727
| +15% | +$11.5M | 1.62% | 8 |
|
|
2013
Q2 | $75M | Buy |
+2,822,796
| New | +$78M | 1.4% | 9 |
|
Other funds holding PFE
Dupont Capital Management's PFE Position: Q3 2023 in Review
Dupont Capital Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 14,575 shares — an estimated $535K sold.
Dupont Capital Management first reported a position in PFE in Q2 2013 and held it in 40 quarters. The position peaked at $97.5M in Q4 2013. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Dupont Capital Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Dupont Capital Management sold 14,575 Pfizer shares in Q3 2023, an estimated $535K.
- Dupont Capital Management first reported a position in Pfizer in Q2 2013 and held it in 40 quarters.
- Dupont Capital Management's Pfizer position peaked at $97.5M in Q4 2013.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.